Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies
Anti-drug antibodies induced by biologic therapeutics often impact drug pharmacokinetics, pharmacodynamics response, clinical efficacy, and patient safety. It is critical to assess the immunogenicity risk of potential biotherapeutics in producing neutralizing and nonneutralizing anti-drug antibodies...
Saved in:
Main Authors: | Michael A. Partridge, Shobha Purushothama, Chinnasamy Elango, Yanmei Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2016/6262383 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic drug monitoring and neutralizing anti-drug antibody detection to optimize TNF-alpha inhibitor treatment for uveitis
by: Howard C. Chen, et al.
Published: (2025-01-01) -
Greek Physicians’ Perceptions on Generic Drugs in the Era of Austerity
by: Georgios Labiris, et al.
Published: (2015-01-01) -
Is it appropriate to call generic drugs copies and copycats?
by: Chittaranjan Andrade
Published: (2023-11-01) -
Discrimination of Anti-Donor Response in Allogeneic Transplantation Using an Alloreactive T-Cell Detection Assay
by: Ryosuke Arata, et al.
Published: (2025-01-01) -
Jenerik / Generic
by: SEFAD Editör
Published: (2016-12-01)